Martin J.S. Dyer
University of Leicester(GB)Washington University in St. Louis(US)
Publications by Year
Research Areas
Chronic Lymphocytic Leukemia Research, Lymphoma Diagnosis and Treatment, Acute Lymphoblastic Leukemia research, Immunodeficiency and Autoimmune Disorders, Chronic Myeloid Leukemia Treatments
Most-Cited Works
- → Increasing the efficacy of CD20 antibody therapy through the engineering of a new type II anti-CD20 antibody with enhanced direct and immune effector cell–mediated B-cell cytotoxicity(2010)938 cited
- → REMISSION INDUCTION IN NON-HODGKIN LYMPHOMA WITH RESHAPED HUMAN MONOCLONAL ANTIBODY CAMPATH-1H(1988)692 cited
- → Assessment of fludarabine plus cyclophosphamide for patients with chronic lymphocytic leukaemia (the LRF CLL4 Trial): a randomised controlled trial(2007)679 cited
- → Bcl10 Is Involved in t(1;14)(p22;q32) of MALT B Cell Lymphoma and Mutated in Multiple Tumor Types(1999)664 cited
- → Ofatumumab As Single-Agent CD20 Immunotherapy in Fludarabine-Refractory Chronic Lymphocytic Leukemia(2010)586 cited
- → Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival(2009)